{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:53:09Z","timestamp":1768744389909,"version":"3.49.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.bbalip.2013.01.008","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T10:53:07Z","timestamp":1358938387000},"page":"880-886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: A potential drug for bipolar disorder"],"prefix":"10.1016","volume":"1831","author":[{"given":"Hiren R.","family":"Modi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireille","family":"Basselin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameer Y.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei O.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalind A.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meir","family":"Bialer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley I.","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2013.01.008_bb0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group","volume":"57","author":"Bowden","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(09)61828-6","article-title":"Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial","volume":"375","author":"Geddes","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jad.2009.12.011","article-title":"The role of valproate in metabolic disturbances in bipolar disorder patients","volume":"124","author":"Chang","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0940-2993(97)80015-2","article-title":"Effects of long-term administration of the antiepileptic drug\u2013sodium valproate upon the ultrastructure of hepatocytes in rats","volume":"49","author":"Sobaniec-Lotowska","year":"1997","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0920-1211(93)90092-L","article-title":"Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedication","volume":"15","author":"Loscher","year":"1993","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0030","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.1840020622","article-title":"Valproate-induced hepatic steatogenesis in rats","volume":"2","author":"Lewis","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","article-title":"Valproate-induced hepatic injury: analyses of 23 fatal cases","volume":"2","author":"Zimmerman","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1042\/bst0130075","article-title":"Valproic acid teratogenicity: demonstration that the biochemical mechanism differs from that of valproate hepatotoxicity","volume":"13","author":"Brown","year":"1985","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0045","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0050","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1997.tb01480.x","article-title":"Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy","volume":"38","author":"Samren","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1990.tb08813.x","article-title":"Arachidonic acid cascade and signal transduction","volume":"55","author":"Shimizu","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0060","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archpsyc.59.7.592","article-title":"Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?","volume":"59","author":"Rapoport","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brainresrev.2009.06.003","article-title":"Bipolar disorder and mechanisms of action of mood stabilizers","volume":"61","author":"Rapoport","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0070","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.nbd.2009.11.010","article-title":"Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients","volume":"37","author":"Kim","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/mp.2009.137","article-title":"Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients","volume":"16","author":"Kim","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0080","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/mp.2009.47","article-title":"Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients","volume":"15","author":"Rao","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0085","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2820055","article-title":"Leukotrienes and lipoxins: structures, biosynthesis, and biological effects","volume":"237","author":"Samuelsson","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0090","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1007\/s11064-008-9731-8","article-title":"Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation","volume":"33","author":"Chang","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0095","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/j.1471-4159.2007.04648.x","article-title":"Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2","volume":"102","author":"Rao","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0100","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1194\/jlr.M006262","article-title":"Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid","volume":"51","author":"Ramadan","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0105","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/sj.npp.1300920","article-title":"Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats","volume":"31","author":"Basselin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0110","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.neuropharm.2011.07.025","article-title":"Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats","volume":"61","author":"Ramadan","year":"2011","journal-title":"Neuropharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.bbalip.2013.01.008_bb0115","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1038\/sj.mp.4001019","article-title":"Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents","volume":"7","author":"Bymaster","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00431272","article-title":"Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide","volume":"67","author":"Post","year":"1980","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.plefa.2008.09.010","article-title":"Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease","volume":"79","author":"Rapoport","year":"2008","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.1989.tb22597.x","article-title":"Deacylation\u2013reacylation of arachidonoyl groups in cerebral phospholipids","volume":"559","author":"Sun","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0135","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1471-4159.2001.00311.x","article-title":"Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers","volume":"77","author":"Chang","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(96)13264-X","article-title":"Lithium decreases turnover of arachidonate in several brain phospholipids","volume":"220","author":"Chang","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00213-005-0059-7","article-title":"Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat","volume":"182","author":"Bazinet","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.biopsych.2005.07.024","article-title":"Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder","volume":"59","author":"Bazinet","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00213-005-0272-4","article-title":"Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder","volume":"184","author":"Bazinet","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbalip.2010.12.006","article-title":"Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: Relevance to valproate's efficacy against bipolar disorder","volume":"1811","author":"Shimshoni","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0165","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3181\/0710-MR-287","article-title":"Mammalian long-chain acyl-CoA synthetases","volume":"233","author":"Soupene","year":"2008","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0170","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1021\/bi047721l","article-title":"Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6","volume":"44","author":"Van Horn","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0175","doi-asserted-by":"crossref","first-page":"30235","DOI":"10.1074\/jbc.M806194200","article-title":"Lysophospholipid acyltransferases and arachidonate recycling in human neutrophils","volume":"283","author":"Gijon","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0180","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4049\/jimmunol.0902257","article-title":"Signaling role for lysophosphatidylcholine acyltransferase 3 in receptor-regulated arachidonic acid reacylation reactions in human monocytes","volume":"184","author":"Perez-Chacon","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-5793(00)01159-5","article-title":"Expression of fatty acid-CoA ligase 4 during development and in brain","volume":"467","author":"Cao","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0190","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000087531","article-title":"Disruption of DMD and deletion of ACSL4 causing developmental delay, hypotonia, and multiple congenital anomalies","volume":"112","author":"Bhat","year":"2006","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0195","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neuroscience.2008.11.056","article-title":"The XLMR gene ACSL4 plays a role in dendritic spine architecture","volume":"159","author":"Meloni","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0200","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ajmg.a.33208","article-title":"Intellectual disability, midface hypoplasia, facial hypotonia, and Alport syndrome are associated with a deletion in Xq22.3","volume":"152A","author":"Rodriguez","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0205","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11064-005-2746-5","article-title":"Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain","volume":"30","author":"Bazinet","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0210","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.bcp.2005.02.012","article-title":"Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives","volume":"69","author":"Eyal","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0215","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1021\/jm7009233","article-title":"Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid","volume":"50","author":"Shimshoni","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0220","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/(SICI)1520-636X(1999)11:8<645::AID-CHIR6>3.0.CO;2-7","article-title":"Enantioselective synthesis and teratogenicity of propylisopropyl acetamide, a CNS-active chiral amide analogue of valproic acid","volume":"11","author":"Spiegelstein","year":"1999","journal-title":"Chirality"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0225","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1023\/A:1016055517724","article-title":"Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide","volume":"13","author":"Bialer","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0230","series-title":"Trans. Soc. Neurochem., Baltimore, MD, March 3\u20137, (2012) PSM11-12","first-page":"118","article-title":"PIA (propylisopropylacetic acid) selectively inhibits acyl-CoA synthetase-4","author":"Modi","year":"2012"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0235","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1023\/A:1015934321764","article-title":"Structure\u2013pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity","volume":"6","author":"Haj-Yehia","year":"1989","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0006-3223(00)00975-6","article-title":"Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder","volume":"49","author":"Ketter","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0245","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0250","series-title":"Understanding Enzymes","author":"Palmer","year":"1985"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0255","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans. Autom. Control."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0260","series-title":"Fitting Models to Biological Data Using Linear and Nonlinear Regression: a Practical Guide to Curve Fitting","first-page":"143","author":"Motulsky","year":"2004"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0265","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1124\/mol.106.030601","article-title":"The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior","volume":"71","author":"Shimshoni","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0270","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1023\/A:1023267224819","article-title":"Valproyl-CoA and esterified valproic acid are not found in brains of rats treated with valproic acid, but the brain concentrations of CoA and acetyl-CoA are altered","volume":"28","author":"Deutsch","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0275","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)22759-8","article-title":"Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment","volume":"250","author":"Loscher","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0280","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1023\/A:1020989701330","article-title":"Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment","volume":"24","author":"Chang","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-8993(00)02893-6","article-title":"Probenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: a microdialysis study","volume":"884","author":"Scism","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0290","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0090-9556(25)08724-0","article-title":"3\u2032-azido-3\u2032-deoxythymidine drug interactions. Screening for inhibitors in human liver microsomes","volume":"20","author":"Rajaonarison","year":"1992","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0295","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0022-3565(24)35377-7","article-title":"Metabolite anion carriers mediate the uptake of the anionic drug fluorescein in renal cortical mitochondria","volume":"292","author":"Terlouw","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0300","doi-asserted-by":"crossref","first-page":"294S","DOI":"10.1093\/jn\/130.2.294S","article-title":"Role of acyl-CoA binding protein in acyl-CoA metabolism and acyl-CoA-mediated cell signaling","volume":"130","author":"Knudsen","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0305","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1021\/tx950216s","article-title":"Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect","volume":"9","author":"Bojic","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0310","first-page":"357","article-title":"Valproic acid, but not its non-teratogenic analogue 2-isopropylpentanoic acid, affects proliferation, viability and neuronal differentiation of the human teratocarcinoma cell line NTera-2","volume":"19","author":"Skladchikova","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0315","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11064-005-2756-3","article-title":"Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat","volume":"30","author":"Lee","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1399-5618.2006.00276.x","article-title":"Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials","volume":"8","author":"Kushner","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0325","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0149-2918(08)80045-8","article-title":"Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy","volume":"30","author":"Ben-Menachem","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0330","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.plefa.2012.06.003","article-title":"Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder","volume":"87","author":"Reese","year":"2012","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0335","doi-asserted-by":"crossref","first-page":"31717","DOI":"10.1074\/jbc.M400100200","article-title":"Structural basis of the substrate-specific two-step catalysis of long chain fatty acyl-CoA synthetase dimer","volume":"279","author":"Hisanaga","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0340","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1194\/jlr.M002469","article-title":"Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation","volume":"51","author":"Basselin","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0345","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1194\/jlr.M700406-JLR200","article-title":"Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat","volume":"49","author":"Lee","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0350","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1046\/j.1471-4159.2003.02246.x","article-title":"Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide","volume":"88","author":"Rosenberger","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0355","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brainresrev.2009.06.003","article-title":"Bipolar disorder and mechanisms of action of mood stabilizers","volume":"61","author":"Rapoport","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0360","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.mp.4001111","article-title":"Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain","volume":"7","author":"Bosetti","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0365","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1471-4159.2003.01701.x","article-title":"Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain","volume":"85","author":"Bosetti","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0370","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.biopsych.2004.05.012","article-title":"Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain","volume":"56","author":"Ghelardoni","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbalip.2013.01.008_bb0375","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1471-4159.2007.04593.x","article-title":"Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation","volume":"102","author":"Basselin","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2013.01.008_bb0380","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neuropharm.2009.01.014","article-title":"Evaluation of the effects of propylisopropylacetic acid (PIA) on neuronal growth cone morphology","volume":"56","author":"Shimshoni","year":"2009","journal-title":"Neuropharmacology"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198113000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198113000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T18:15:57Z","timestamp":1745950557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198113000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1388198113000267"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2013.01.008","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: A potential drug for bipolar disorder","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2013.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}